Virology Education, P: +31302307140 F: +31302307148, E: info@virology-education.com

www.virology-education.com

1- 3 June 2011, Milan Marriott Hotel, Milan, Italy

Again in 2011: Pre-workshop educational course for practicing clinicians

Virology Education, P: +31302307140 F: +31302307148, E: info@virology-education.com

www.virology-education.com

David Back, MD, University of Liverpool, UK:Drug Drug Interactions

Marco Cavaleri, MD, EMA, London, UK:Regulatory issues with the clinical testing of the new HCV compounds

Marion Peters, MD, University of California, San Francisco, USAHIV/HBV coinfection in chronic kidney disease

Jürgen Rockstroh, MD, University of Bonn, Germany Acute HCV: overview ongoing cohort studies

Mark Sulkowski, MD, Johns Hopkins University, USAExpert’s overview of the latest data presented at the EASL

Kenneth Sherman, MD, PhD, University of Cincinnati College of Medicine, USAExpert’s overview of the latest data presented at the CROI

Stefan Zeuzem, MD, J.W. Goethe University Hospital, Frankfurt, GermanyNew DAA’s for Treatment of Hepatitis C: Promises and Challenges

CONFIRMED SPEAKERS

Virology Education, P: +31302307140 F: +31302307148, E: info@virology-education.com

www.virology-education.com

REGISTRATION AND ABSTRACT SUBMISSION

Abstract topics:- Immunology of HCV - Interactions between antiretrovirals and anti-HBV and anti-HCV agents- Treatment issues on HCV-HIV- Treatment issues on HBV-HIV - HCV resistance- HBV resistance- New anti-HCV drugs- Non invasive assessment of liver fibrosis- Liver steatosis- Liver toxicity- Liver cancer- Liver transplantation- Delta Hepatitis

Deadline abstract submission: 1 April 2011

Registration timeline:

Early :  1 Feb.  - 15 March 2011Regular :  16 March - 15 April 2011Late :  16 April  - 15 May 2011  On-Site : 1, 2 and 3 June 2011